- Investing Ideas
- /
- Danish Pharmaceuticals & Biotech Large Cap High Growth Potential
Danish Pharmaceuticals & Biotech Large Cap High Growth Potential
Results
2
0 new
Large Cap Companies that analysts expect to have high earnings, revenue or cash flow growth in the next 3 years.
2 companies
Novo Nordisk
Market Cap: DKK 1.6t
Engages in the research and development, manufacture, and distribution of pharmaceutical products in Europe, the Middle East, Africa, Mainland China, Hong Kong, Taiwan, North America, and internationally.
NOVO B
DKK 361.10
7D
-8.0%
1Y
-56.7%
Genmab
Market Cap: DKK 114.0b
A biotechnology company, develops antibody-based products and product candidates for the treatment of cancer and other diseases in Denmark.
GMAB
DKK 1,852.50
7D
4.3%
1Y
16.0%